Artemis Investment Management LLP
Position in ANIP — Ani Pharmaceuticals Inc
CIK 1535385
EDINBURGH, X0
Position in ANIP
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$2,332,409
+$1,144,228 QoQ
Shares Held
28,176
+82.4% QoQ
Ownership
0.123%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#106
of 305 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANIP Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Artemis Investment Management LLP holds $81,674,270 across 5 Drug Manufacturers - Specialty & Generic names. ANIP ranks #4 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
2,966,646 | $73,009,158 | |
| 2 | AMRX |
Amneal Pharmaceuticals, Inc.
|
186,125 | $3,221,823 | |
| 3 | COLL |
Collegium Pharmaceutical, Inc
|
68,573 | $2,482,342 | |
| 4 | ANIP |
Ani Pharmaceuticals Inc
This page
|
28,176 | $2,332,409 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
15,319 | $628,538 |
All Filings in ANIP
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,332,409 | 28,176 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $1,188,181 | 15,451 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $1,706,445 | 21,617 | Shares | Sole | 2026-02-02 | |
| No filing history on record for this holder in this stock. | ||||||